Xeris Biopharma Holdings, Inc. (XERS)
6.10
-0.02
(-0.33%)
USD |
NASDAQ |
Mar 02, 14:48
Xeris Biopharma Holdings Research and Development Expense (TTM) : 29.38M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| IDEXX Laboratories, Inc. | 251.21M |
| Harrow, Inc. | 13.97M |
| Vir Biotechnology, Inc. | 432.80M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |